Mycobacterium tuberculosis (M.tb) and SARS-CoV-2 are both infections that can lead to severe disease in the lower lung. However, these two infections are caused by very different pathogens (Mycobacterium vs. virus), they have different mechanisms of pathogenesis and immune response, and differ in how long the infection lasts. Despite the differences, SARS-CoV-2 and M.tb share a common feature, which is also frequently observed in other respiratory infections: the burden of disease in the elderly is greater. Here, we discuss possible reasons for the higher burden in older adults, including the effect of co-morbidities, deterioration of the lung environment, auto-immunity, and a reduced antibody response. While the answer is likely to be multifactorial, understanding the main drivers across different infections may allow us to design broader interventions that increase the health-span of older people.
CITATION STYLE
Allué-Guardia, A., Torrelles, J. B., & Sigal, A. (2023). Tuberculosis and COVID-19 in the elderly: factors driving a higher burden of disease. Frontiers in Immunology. Frontiers Media SA. https://doi.org/10.3389/fimmu.2023.1250198
Mendeley helps you to discover research relevant for your work.